Vaccine X: Regional progress and persistent gaps: toward measles elimination in Asia and the Pacific
A recent editorial in the journal Vaccine X examines the progress towards measles elimination in Asia and the Pacific Region. With a focus on measles in the Philippines, the authors explore how programmatic and social cultural barriers enable ongoing measles transmission.
Read the article in full: Regional progress and persistent gaps: toward measles elimination in Asia and the Pacific
For more information about measles disease, epidemiology and prevention, visit MVEC: Sởi.
Immunisation Coalition: 2026 Meningococcal Webinar
Next month, the Immunisation Coalition will host a webinar providing an update on invasive meningococcal disease. Moderated by Dr Andrew Baird, the webinar will feature Prof Jim Buttery.
Ngày: 25 February 2026
Thời gian: 6:00–7:00 pm (AEDT)
Learn more and register on the Immunisation Coalition's event page.
Options XIII: Registrations and abstract submissions now open
Các International Society for Respiratory Viruses’ Options XIII Conference for the Control of Influenza will be held in Washington, DC, USA.
Ngày: 30 August to 2 September 2026
Địa điểm: Walter Washington Convention Center, Washington, DC, USA
Visit the conference website for more details about the event and to see important dates and deadlines.
Reminder: Japanese encephalitis vaccination
This mosquito season, people travelling to regions where Japanese encephalitis virus (JEV) is present should take precautions to be protected. Protection may include physical barriers (e.g. long, loose clothing, DEET, mosquito nets) and vaccination.
Japanese encephalitis is a leading cause of vaccine-preventable encephalitis in Asia and the Western Pacific.
Vaccination is recommended for those at highest risk of exposure so JEV. Some individuals are prioritised and funded to receive vaccines through state-led programs.
For detailed information, visit MVEC: Viêm não Nhật Bản
BBC: US panel votes to end recommending hepatitis B vaccine for all newborns
The US-based Advisory Committee on Immunization Practices (ACIP) now recommends individual-based decision-making for hepatitis B vaccination in babies born to mothers who have tested negative for liver infection.
According to BBC, public health experts worry ACIP’s decision will raise unfounded safety concerns about the vaccine.
Up to 90% of those infected with hepatitis B in infancy will go on to develop chronic infection. Chronic hepatitis B can lead to cirrhosis, liver failure, liver cancer and death. There is no cure for chronic hepatitis B.
Đọc toàn bộ bài viết ở đây: BBC: US panel votes to end recommending hepatitis B vaccine for all newborns
For stories of those affected by hepatitis B, visit BBC: They contracted hepatitis before the vaccine was given at birth – now the shot may be delayed again
Read more about hepatitis B disease, epidemiology, transmission and vaccination at MVEC: Viêm gan B
ATAGI statement on the importance and safety of hepatitis B vaccine at birth
On 11 December 2025, the Nhóm tư vấn kỹ thuật về tiêm chủng Úc (ATAGI) released a statement on the importance and safety of hepatitis B vaccination at birth.
ATAGI outlines reasons for their birth dose recommendations, including:
- Screening during pregnancy does not always occur
- The pregnant person may become infected after screening
- Transmission from another household member to the baby may occur
- Babies infected at birth have about a 90% chance of developing chronic hepatitis B
Read the full statement at ATAGI statement on the importance and safety of hepatitis B vaccine at birth.
For more information about hepatitis B disease, transmission, epidemiology and vaccination, visit MVEC: Viêm gan B.
MVEC education on social media
MVEC shares evidence-based vaccine education on social media. This up-to-date material provides accessible information for healthcare professionals and the general public alike, and can be used as an education tool.
Support MVEC by following us on Instagram and sharing reliable vaccine content on social media.
Unbiased Science: Evidence, Not Guesswork: The Childhood Vaccine Schedule is Very Intentional
Public health expert and science communicator Dr Jess Steier and colleagues have recently published an article illustrating how the US recommended vaccine schedule is built on clinical trial data and ongoing safety monitoring.
The article covers why vaccines are given at different timepoints, who determines the schedule, how new vaccines are added and how vaccines are continually monitored.
Read the article in full at Evidence, Not Guesswork: The Childhood Vaccine Schedule is Very Intentional
NCIRS: Influenza vaccines – FAQs
Các National Centre for Immunisation Research and Surveillance (NCIRS) recently updated its Influenza vaccines FAQs page to include a new section with answers to common question about the intranasal flu vaccine FluMist.
Visit the NCIRS Influenza vaccines – FAQs trang.
For more information about influenza disease, transmission and protection, visit MVEC: Cúm.
Melbourne Ageing Well Expo: 20–21 March 2026
MVEC will be an exhibitor at next year’s Ageing Well Expo. The expo showcases the latest innovations in health, aged care, lifestyle and wellbeing. Registrations open Friday 12 December.
Lear more on the Ageing Well Expo website.
Ngày: 20–21 March 2026
Địa điểm: Melbourne Convention & Exhibition Centre
